Development
of highly efficient near-infrared (NIR)-excited
photosensitizers
is hampered by the fast nonradiative vibrational relaxation process
regulated by the energy gap law. Here, from the fundamental perspective
we propose that the intermolecular coupling of well-designed photosensitizers
has the potential to facilitate exciton delocalization and hence reduce
the exciton–vibration coupling, thereby boosting their phototherapeutic
efficacy via inhibition of the vibrational relaxation pathway. Such
conceived NIR-excited metallo-photosensitizers (IrHA1 and IrHA2) were
prepared and studied for experimental validation. The resulting iridium
complexes exhibited a little singlet oxygen (1O2) production in the monomeric state, but produced substantially enhanced 1O2 generation efficiency via benefiting from the
exciton–vibration decoupling in the self-assembly state. Particularly,
IrHA2 exhibits an unprecedented high 1O2 quantum
yield of 54.9% (FDA-approved NIR dye indocyanine green: ΦΔ = 0.2%) under 808 nm laser irradiation with negligible
heat generation, probably attributed to the suppression of vibronic
couplings from the stretching mode of the acceptor ligand. In phototherapy,
IrHA2-NPs with high biocompatibility and low dark toxicity can induce
substantial tumor regression with 92.9% tumor volume reduction in
vivo. This self-assembly-induced vibronic decoupling strategy would
offer an effective approach to the design of high-performance NIR-excited
photosensitizers.